LEXINGTON, Mass., June 16, 2011 /PRNewswire-USNewswire/ -- Cubist Pharmaceuticals, Inc. today praised Rep. Phil Gingrey, R-Ga., and co-sponsors for introducing the Generating Antibiotic Incentives Now (GAIN) Bill of 2011.

CHICAGO, June 3, 2011 /PRNewswire/ -- Seven Summits Research issues critical PriceWatch Alerts for MA, SINA, AET, PLD, and CBST. To see what our analysts have discovered about these stocks read the Seven Summits Strategic Investments' PriceWatch Alerts at http://www.iotogo.com/s/060311A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover the following stocks: MasterCard Incorporated (NYSE: MA), Sina Corp.

VANCOUVER, British Columbia, May 24, 2011 /PRNewswire-Asia/ -- Insiderslab.com today issued reports highlighted the respectable insider transactions for Dell, Lowe's, Petrohawk Energy, eBay, Cubist Pharmaceuticals, & Starbucks. Besides of reporting direct ownerships and transactions, corporate insiders have to file their indirect holdings made by their relatives as well.

SAN DIEGO, April 6, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the signing of an exclusive two-year co-promotion agreement to market DIFICID(TM) (fidaxomicin), in the United States.

UPPSALA, Sweden, May 25 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST).